Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128979) titled 'Study on Standardized Specimen Processing Following En Bloc Resection of Bladder Tumors for Improved Pathological Diagnosis' on July 29.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: Liuzhou people's hospital

Condition: Bladder Cancer

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-09-01

Target Sample Size: ESD-like specimen handling protocol Group:64;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=334369

Published by HT Digital Content Services with permission from Health Daily Digest....